T1	Pharmacological_substance 30 40	leucovorin
N1000 	Reference T1 MeSH:D002955	leucovorin
T2	Pharmacological_substance 52 66	5-fluorouracil
N1001 	Reference T2 MeSH:D005472	5-fluorouracil
T3	Disorder 70 99	advanced colorectal carcinoma
N1 	Reference T3 UMLS:C0007097	advanced colorectal carcinoma
T5	Pharmacological_substance 198 210	fluorouracil
N1002 	Reference T5 MeSH:D005472	fluorouracil
T6	Pharmacological_substance 221 231	leucovorin
N1003 	Reference T6 MeSH:D002955	leucovorin
T7	Disorder 293 319	advanced colorectal cancer
N2 	Reference T7 UMLS:C0006826	advanced colorectal cancer
N3 	Reference T7 UMLS:C1306459	advanced colorectal cancer
T9	Pharmacological_substance 478 480	FU
N1004 	Reference T9 MeSH:D005472	FU
T11	Pharmacological_substance 637 649	fluorouracil
N1005 	Reference T11 MeSH:D005472	fluorouracil
T12	Disorder 702 730	metastatic colorectal cancer
N4 	Reference T12 UMLS:C2939419	metastatic colorectal cancer
T15	Pharmacological_substance 848 850	FU
N1006 	Reference T15 MeSH:D005472	FU
T17	Pharmacological_substance 1029 1031	FU
N1007 	Reference T17 MeSH:D005472	FU
T19	Pharmacological_substance 1051 1053	FU
N1008 	Reference T19 MeSH:D005472	FU
T24	Disorder 1277 1288	weight loss
N5 	Reference T24 UMLS:C1262477	weight loss
T25	Disorder 1320 1328	toxicity
N6 	Reference T25 UMLS:C0600688	toxicity
T26	Disorder 1344 1354	stomatitis
N7 	Reference T26 UMLS:C0038362	stomatitis
T28	Disorder 1368 1376	diarrhea
N8 	Reference T28 UMLS:C0011991	diarrhea
T30	Disorder 1394 1400	nausea
N9 	Reference T30 UMLS:C0027497	nausea
T32	Pharmacological_substance 1544 1546	FU
N1009 	Reference T32 MeSH:D005472	FU
T33	Disorder 1556 1582	advanced colorectal cancer
N10 	Reference T33 UMLS:C0006826	advanced colorectal cancer
N11 	Reference T33 UMLS:C1306459	advanced colorectal cancer
T34	Pharmacological_substance 1653 1655	FU
N1010 	Reference T34 MeSH:D005472	FU
T35	Pharmacological_substance 1695 1697	FU
N1011 	Reference T35 MeSH:D005472	FU
T36	Pharmacological_substance 1767 1769	FU
N1012 	Reference T36 MeSH:D005472	FU
T37	Pharmacological_substance 1859 1861	FU
N1013 	Reference T37 MeSH:D005472	FU
T38	Disorder 1979 2005	advanced colorectal cancer
N12 	Reference T38 UMLS:C0006826	advanced colorectal cancer
N13 	Reference T38 UMLS:C1306459	advanced colorectal cancer
T4	Pharmacological_substance 233 235	LV
N1014 	Reference T4 MeSH:D002955	LV
T39	Pharmacological_substance 212 214	FU
N1015 	Reference T39 MeSH:D005472	FU
T40	Pharmacological_substance 1827 1829	FU
N1016 	Reference T40 MeSH:D005472	FU
T42	Pharmacological_substance 347 349	LV
N1017 	Reference T42 MeSH:D002955	LV
T43	Pharmacological_substance 355 357	FU
N1018 	Reference T43 MeSH:D005472	FU
T44	Combination 350 354	plus
T45	Combination 216 220	plus
T46	Pharmacological_substance 788 790	LV
N1019 	Reference T46 MeSH:D002955	LV
T47	Pharmacological_substance 766 768	FU
N1020 	Reference T47 MeSH:D005472	FU
T48	Pharmacological_substance 1059 1061	LV
N1021 	Reference T48 MeSH:D002955	LV
T49	Combination 1054 1058	plus
T20	Pharmacological_substance 1670 1672	LV
N1022 	Reference T20 MeSH:D002955	LV
T22	Pharmacological_substance 1438 1440	FU
N1023 	Reference T22 MeSH:D005472	FU
T23	Pharmacological_substance 1446 1448	LV
N1024 	Reference T23 MeSH:D002955	LV
T27	Combination 1441 1445	plus
T29	Pharmacological_substance 1538 1540	LV
N1025 	Reference T29 MeSH:D002955	LV
T31	Pharmacological_substance 1530 1532	FU
N1026 	Reference T31 MeSH:D005472	FU
T50	Combination 1533 1537	plus
T51	Pharmacological_substance 1703 1705	LV
N1027 	Reference T51 MeSH:D002955	LV
T52	Combination 1698 1702	plus
T53	Pharmacological_substance 1876 1878	LV
N1028 	Reference T53 MeSH:D002955	LV
T54	Pharmacological_substance 1947 1949	FU
N1029 	Reference T54 MeSH:D005472	FU
T41	Subject 858 896	Three hundred nine of the 310 patients
T55	Subject 674 682	Patients
T56	Disorder 688 698;713 730	inoperable colorectal cancer
N14 	Reference T56 UMLS:C0006826	inoperable colorectal cancer
N15 	Reference T56 UMLS:C1306459	inoperable colorectal cancer
T57	Combination 783 787	plus
T59	Subject 984 992	patients
T60	Disorder 998 1016	measurable disease
N16 	Reference T60 UMLS:C0025007	measurable disease
T61	Combination 14 20	adding
T10	Subject 653 672	both treatment arms
T21	Combination 1656 1660	with
T65	Combination 1862 1866	with
